AdaptHealth Corp. (NASDAQ: AHCO), a medical equipment maker, reported significant double-digit first-quarter revenue growth and a major share repurchase program. In May 10 trading, AHCO prices closed to $14.14.
Top 5 Tech Stocks to Buy in 2024
Don't let the chaos of rising interest rates, potential recession, tighter credit issues, higher oil prices, and incessant geopolitical issues chase you from the markets. Instead, just wait it out. With too much fear in the market, go bargain hunting with tech stocks. We have complied a report with the five of the best ways to profit within this industry.
"Top 5 AI Stocks to Buy in 2024."
Click here to sign up for our free report & newsletter, plus bonus offer "Elon Musk just Tiggered a BOOM in These Stocks"
Sponsored
AHCO stock boosted sales by 46.5% to $706.2 million in the last quarter. Compared to a loss of $4 million and $0.08 per share a year ago, net income was $41.8 million, or $0.08 per share. From $18.4 million a year ago, operating cash flow increased to $66.5 million. The firm turned a profit and announced intentions to buy back $200 million in stock before the year’s end.
AdaptHealth Corp. (AHCO) has completed six acquisitions in the last year and began integrating the Community Surgical Supply company in the first quarter, which manufactures medical equipment and supplies ranging from IVs to ventilators.
As a result, AdaptHealth originates from the tumultuous COVID-19 crisis, when medicine was preoccupied with combating the coronavirus. AHCO now has the chance to recover sales and earnings in important categories such as medical equipment rentals, hospital beds, diabetes monitoring systems, and home medical equipment, thanks to more recommendations to healthcare providers.
Furthermore, according to AdaptHealth CEO Steve Griggs, CPAP devices, which are used to treat sleep apnea at home, have less supply difficulties. This is one of AdaptHealth’s most important business sectors.
AdaptHealth Corp. (AHCO) has raised its sales projection for the current year to $2.84- $3.04 billion, with EBITDA in the region of $615- $675 million.
The shares of AHCO rose 4.59% last week and fell -7.03 percent during the previous month. The shares of this firm have slumped -21.40% in the previous quarter. The stock has been down -42.17 percent in the previous six months, with a full-year loss of -42.96%. This stock’s year-to-date (YTD) price performance is presently negative at -42.19% as of this writing.
